<code id='412CB2141E'></code><style id='412CB2141E'></style>
    • <acronym id='412CB2141E'></acronym>
      <center id='412CB2141E'><center id='412CB2141E'><tfoot id='412CB2141E'></tfoot></center><abbr id='412CB2141E'><dir id='412CB2141E'><tfoot id='412CB2141E'></tfoot><noframes id='412CB2141E'>

    • <optgroup id='412CB2141E'><strike id='412CB2141E'><sup id='412CB2141E'></sup></strike><code id='412CB2141E'></code></optgroup>
        1. <b id='412CB2141E'><label id='412CB2141E'><select id='412CB2141E'><dt id='412CB2141E'><span id='412CB2141E'></span></dt></select></label></b><u id='412CB2141E'></u>
          <i id='412CB2141E'><strike id='412CB2141E'><tt id='412CB2141E'><pre id='412CB2141E'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:63
          Daphne Koller -- biotech coverage from STAT
          Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

          New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

          Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

          advertisement

          But what exactly is Koller building?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          What don’t we know about an Alzheimer’s drug side effect?
          What don’t we know about an Alzheimer’s drug side effect?

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSincetheFDA’sapprovaloflecanemab(marketedasLeqembi)andMe

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          IRA could hurt research into orphan drugs for rare diseases

          AdobeThistimelastyear,membersofCongresswereworkingaroundtheclocktodraftandpasstheInflationReductionA